Fate Therapeutics FATE
NASDAQ FATE
$2.48 +0.06 (+2.48%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fate Therapeutics (FATE) Amortizatization of Intangibles (2012 - 2026)

Fate Therapeutics' (FATE) quarterly Amortizatization of Intangibles came in at $772000.0 in Q1 2026, down 27.72% YoY from $1.1 million in Q1 2025, and down 12.37% on a QoQ basis from $881000.0 in Q4 2025.

Analysis

Fate Therapeutics (FATE) Amortizatization of Intangibles (2012 - 2026) Analysis & Trends

Fate Therapeutics (FATE) has 12 years of Amortizatization of Intangibles data on file, last reported at $772000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 27.72% year-over-year to $772000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (down 55.97% YoY) and the FY2025 annual result came in at $3.6 million, down 60.29% from the prior year.
  • Amortizatization of Intangibles retreated to $772000.0 in Q1 2026, from $881000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $3.3 million in Q3 2023 to a low of -$873000.0 in Q1 2022.
  • A 5-year average of $1.5 million and a median of $1.2 million in 2022 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 696.33% — and 2025, when it slumped 68.89%.
  • Tracing FATE's Amortizatization of Intangibles over 5 years: stood at $1.2 million in 2022, then jumped by 133.41% to $2.9 million in 2023, then plunged by 47.35% to $1.5 million in 2024, then tumbled by 42.42% to $881000.0 in 2025, then fell by 12.37% to $772000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $772000.0 (Q1 2026), $881000.0 (Q4 2025), and $810000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Fate Therapeutics 299.79 Mn 299.79 Mn - 764,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 764,000.00
Mar 31, 2026 772,000.00
Dec 31, 2025 881,000.00
Sep 30, 2025 810,000.00
Jun 30, 2025 847,000.00
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.53 Mn
Sep 30, 2024 2.20 Mn
Jun 30, 2024 2.72 Mn
Mar 31, 2024 2.63 Mn
Dec 31, 2023 2.91 Mn
Sep 30, 2023 3.26 Mn
Jun 30, 2023 2.94 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 1.25 Mn
Sep 30, 2022 409,000.00
Jun 30, 2022 -525,000.00
Mar 31, 2022 -873,000.00
Dec 31, 2021 -1.07 Mn
Sep 30, 2021 -1.37 Mn